Advertisement
Screener

Exelixis Inc (EXEL) Diluted Shares Outstanding (Weighted Average)

2.8 / 5 stars · 68/120 Roast Me

Exelixis Inc Diluted Shares Outstanding (Weighted Average)

Exelixis Inc (EXEL) reported Diluted Shares Outstanding (Weighted Average) of 259.68 million shares for the 3-month period ending 2026-07-03, per its 10-Q filed 2026-08-05.

Financial Statements › Income Statement › Earnings Per Share

us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding · last filed 2026-08-05

  • Exelixis Inc weighted average number of shares outstanding, diluted for the quarter ending 2026-07-03 was 259.68M shares, a 8.69% decline year-over-year.
  • Exelixis Inc weighted average number of shares outstanding, diluted for the quarter ending 2026-04-03 was 267.32M shares, a 7.24% decline year-over-year.
  • Exelixis Inc weighted average number of shares outstanding, diluted for the quarter ending 2026-01-02 was 276.35M shares, a 5.86% decline year-over-year.
  • Exelixis Inc weighted average number of shares outstanding, diluted for the quarter ending 2025-10-03 was 278.54M shares, a 4.44% decline year-over-year.
  • Exelixis Inc weighted average number of shares outstanding, diluted for fiscal 2026 was 281.86M shares, a 4.82% decline from fiscal 2025.
  • Exelixis Inc weighted average number of shares outstanding, diluted for fiscal 2025 was 296.13M shares, a 7.88% decline from fiscal 2023.
  • Exelixis Inc weighted average number of shares outstanding, diluted for fiscal 2023 was 321.46M shares, a 0.95% decline from fiscal 2022.
  • Exelixis Inc weighted average number of shares outstanding, diluted for fiscal 2022 was 324.56M shares, a 0.68% increase from fiscal 2021.
Period endWeighted Average Number of Shares Outstanding, Diluted 3 monthWeighted Average Number of Shares Outstanding, Diluted 3 month as first filedWeighted Average Number of Shares Outstanding, Diluted 6 monthWeighted Average Number of Shares Outstanding, Diluted 9 monthWeighted Average Number of Shares Outstanding, Diluted 9 month as first filedWeighted Average Number of Shares Outstanding, Diluted 12 month
2026-07-03259.68M shares
10-Q · filed 2026-08-05
263.50M shares
10-Q · filed 2026-08-05
267.78M shares
derived: average of 3 quarters · filed 2026-08-05
270.47M shares
derived: average of 4 quarters · filed 2026-08-05
2026-04-03267.32M shares
10-Q · filed 2026-05-05
271.84M shares
derived: average of 2 quarters · filed 2026-05-05
274.07M shares
derived: average of 3 quarters · filed 2026-05-05
276.65M shares
derived: average of 4 quarters · filed 2026-08-05
2026-01-02276.35M shares
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-10
277.44M shares
derived: average of 2 quarters · filed 2026-02-10
279.76M shares
derived: average of 3 quarters · filed 2026-08-05
281.86M shares
10-K · filed 2026-02-10
2025-10-03278.54M shares
10-Q · filed 2025-11-04
281.46M shares
derived: average of 2 quarters · filed 2026-08-05
283.70M shares
10-Q · filed 2025-11-04
286.16M shares
derived: average of 4 quarters · filed 2026-08-05
2025-07-04284.39M shares
10-Q · filed 2026-08-05
286.29M shares
10-Q · filed 2026-08-05
288.71M shares
derived: average of 3 quarters · filed 2026-08-05
289.40M shares
derived: average of 4 quarters · filed 2026-08-05
2025-04-04288.18M shares
10-Q · filed 2026-05-05
290.86M shares
derived: average of 2 quarters · filed 2026-05-05
291.07M shares
derived: average of 3 quarters · filed 2026-05-05
291.79M shares
derived: average of 4 quarters · filed 2026-05-05
2025-01-03293.55M shares
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-10
292.51M shares
derived: average of 2 quarters · filed 2026-02-10
293.00M shares
derived: average of 3 quarters · filed 2026-02-10
296.13M shares
10-K · filed 2026-02-10
2024-09-27291.48M shares
10-Q · filed 2025-11-04
292.73M shares
derived: average of 2 quarters · filed 2025-11-04
296.99M shares
10-Q · filed 2025-11-04
301.00M shares
derived: average of 4 quarters · filed 2026-02-10
2024-06-28293.97M shares
10-Q · filed 2025-07-28
299.75M shares
10-Q · filed 2025-07-28
304.18M shares
derived: average of 3 quarters · filed 2026-02-10
307.94M shares
derived: average of 4 quarters · filed 2026-02-10
2024-03-29305.53M shares
10-Q · filed 2025-05-13
309.28M shares
derived: average of 2 quarters · filed 2026-02-10
312.60M shares
derived: average of 3 quarters · filed 2026-02-10
316.28M shares
derived: average of 4 quarters · filed 2026-02-10
2023-12-29313.02M shares
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-10
316.14M shares
derived: average of 2 quarters · filed 2026-02-10
319.86M shares
derived: average of 3 quarters · filed 2026-02-10
321.46M shares
10-K · filed 2026-02-10
2023-09-29319.25M shares
10-Q · filed 2024-10-29
323.28M shares
derived: average of 2 quarters · filed 2024-10-29
324.28M shares
10-Q · filed 2024-10-29
324.45M shares
derived: average of 4 quarters · filed 2025-02-11
2023-06-30327.31M shares
10-Q · filed 2024-08-06
326.79M shares
10-Q · filed 2024-08-06
326.18M shares
derived: average of 3 quarters · filed 2025-02-11
325.90M shares
derived: average of 4 quarters · filed 2025-02-11
2023-03-31326.28M shares
10-Q · filed 2024-04-30
325.62M shares
derived: average of 2 quarters · filed 2025-02-11
325.44M shares
derived: average of 3 quarters · filed 2025-02-11
325.30M shares
derived: average of 4 quarters · filed 2025-02-11
2022-12-30324.96M shares
derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-11
325.01M shares
derived: average of 2 quarters · filed 2025-02-11
324.98M shares
derived: average of 3 quarters · filed 2025-02-11
324.56M shares
10-K · filed 2025-02-11
2022-09-30325.07M shares
10-Q · filed 2023-11-01
324.99M shares
derived: average of 2 quarters · filed 2023-11-01
324.42M shares
10-Q · filed 2023-11-01
324.11M shares
derived: average of 4 quarters · filed 2024-02-06
2022-07-01324.90M shares
10-Q · filed 2023-08-01
324.10M shares
10-Q · filed 2023-08-01
323.79M shares
derived: average of 3 quarters · filed 2024-02-06
323.35M shares
derived: average of 4 quarters · filed 2024-02-06
2022-04-01323.29M shares
10-Q · filed 2023-05-09
323.24M shares
derived: average of 2 quarters · filed 2024-02-06
322.83M shares
derived: average of 3 quarters · filed 2024-02-06
322.86M shares
derived: average of 4 quarters · filed 2024-02-06
2021-12-31323.18M shares
derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-06
322.60M shares
derived: average of 2 quarters · filed 2024-02-06
322.72M shares
derived: average of 3 quarters · filed 2024-02-06
322.36M shares
10-K · filed 2024-02-06
2021-10-01322.02M shares
10-Q · filed 2022-11-01
322.48M shares
derived: average of 2 quarters · filed 2022-11-01
322.08M shares
10-Q · filed 2022-11-01
321.44M shares
derived: average of 4 quarters · filed 2023-02-07
2021-07-02322.94M shares
10-Q · filed 2022-08-09
322.11M shares
10-Q · filed 2022-08-09
321.25M shares
derived: average of 3 quarters · filed 2023-02-07
318.22M shares
derived: average of 4 quarters · filed 2023-02-07
2021-04-02321.29M shares
10-Q · filed 2022-05-10
320.40M shares
derived: average of 2 quarters · filed 2023-02-07
316.64M shares
derived: average of 3 quarters · filed 2023-02-07
317.02M shares
derived: average of 4 quarters · filed 2023-02-07
2021-01-01319.52M shares
derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-07
314.32M shares
derived: average of 2 quarters · filed 2023-02-07
315.59M shares
derived: average of 3 quarters · filed 2023-02-07
318.00M shares
10-K · filed 2023-02-07
2020-10-02309.12M shares
10-Q · filed 2021-11-02
313.63M shares
derived: average of 2 quarters · filed 2021-11-02
317.50M shares
10-Q · filed 2021-11-02
314.50M shares
derived: average of 4 quarters · filed 2022-02-18
2020-07-03318.14M shares
10-Q · filed 2021-08-05
316.99M shares
10-Q · filed 2021-08-05
316.29M shares
derived: average of 3 quarters · filed 2022-02-18
316.08M shares
derived: average of 4 quarters · filed 2022-02-18
2020-04-03315.84M shares
10-Q · filed 2021-05-06
315.37M shares
derived: average of 2 quarters · filed 2022-02-18
315.40M shares
derived: average of 3 quarters · filed 2022-02-18
315.28M shares
derived: average of 4 quarters · filed 2022-02-18
2020-01-03314.90M shares
derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-18
315.18M shares
derived: average of 2 quarters · filed 2022-02-18
315.09M shares
derived: average of 3 quarters · filed 2022-02-18
315.01M shares
10-K · filed 2022-02-18
2019-09-27315.45M shares
10-Q · filed 2020-11-05
315.18M shares
derived: average of 2 quarters · filed 2020-11-05
315.05M shares
10-Q · filed 2020-11-05
314.15M shares
derived: average of 4 quarters · filed 2020-11-05
2019-06-28314.91M shares
10-Q · filed 2020-08-06
314.79M shares
10-Q · filed 2020-08-06
313.72M shares
derived: average of 3 quarters · filed 2020-08-06
313.38M shares
derived: average of 4 quarters · filed 2020-08-06
2019-03-29314.64M shares
10-Q · filed 2020-05-05
313.13M shares
derived: average of 2 quarters · filed 2020-05-05
312.87M shares
derived: average of 3 quarters · filed 2020-05-05
312.71M shares
derived: average of 4 quarters · filed 2020-05-05
2018-12-28311.61M shares
derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-25
311.98M shares
derived: average of 2 quarters · filed 2020-02-25
312.07M shares
derived: average of 3 quarters · filed 2020-02-25
312.80M shares
10-K · filed 2021-02-11
2018-09-28312.35M shares
10-Q · filed 2019-10-30
312.29M shares
derived: average of 2 quarters · filed 2019-10-30
313.20M shares
10-Q · filed 2019-10-30
312.91M shares
derived: average of 4 quarters · filed 2020-02-25
2018-06-29312.24M shares
10-Q · filed 2019-07-31
313.02M shares
10-Q · filed 2019-07-31
313.09M shares
derived: average of 3 quarters · filed 2020-02-25
313.05M shares
derived: average of 4 quarters · filed 2020-02-25
2018-03-30313.69M shares
10-Q · filed 2019-05-01
313.52M shares
derived: average of 2 quarters · filed 2020-02-25
313.33M shares
derived: average of 3 quarters · filed 2020-02-25
2017-12-29313.35M shares
derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-25
313.14M shares
derived: average of 2 quarters · filed 2020-02-25
312.00M shares
10-K · filed 2020-02-25
2017-09-30312.94M shares
10-Q · filed 2017-11-01
311.56M shares
10-Q · filed 2017-11-01
2017-09-29312.94M shares
10-Q · filed 2018-11-01
312.08M shares
derived: average of 2 quarters · filed 2018-11-01
311.56M shares
10-Q · filed 2018-11-01
2017-06-30311.22M shares
10-Q · filed 2018-08-01
310.76M shares
10-Q · filed 2017-08-02
2017-03-31309.54M shares
10-Q · filed 2017-05-01
2016-12-30250.53M shares
10-K · filed 2019-02-22
2016-09-30256.32M shares
10-Q · filed 2017-11-01
242.81M shares
derived: average of 2 quarters · filed 2017-11-01
238.02M shares
10-Q · filed 2017-11-01
2016-06-30229.31M shares
10-Q · filed 2017-08-02
228.86M shares
10-Q · filed 2017-08-02
2016-03-31228.30M shares
10-Q · filed 2017-05-01
2016-01-01209.23M shares
10-K · filed 2018-02-26
2013-12-31184.06M shares
10-K · filed 2014-02-20
2012-12-31183.60M shares
derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-20
174.98M shares
derived: average of 2 quarters · filed 2014-02-20
160.14M shares
10-K · filed 2014-02-20
2012-09-30166.35M shares
10-Q · filed 2012-11-07
152.32M shares
10-Q · filed 2012-11-07
2011-12-31133.63M shares
derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-20
132.49M shares
derived: average of 2 quarters · filed 2014-02-20
130.48M shares
10-K · filed 2014-02-20
2011-09-30131.34M shares
10-Q · filed 2012-11-07
131.34K shares
10-Q · filed 2011-10-27
129.43M shares
10-Q · filed 2012-11-07
129.43K shares
10-Q · filed 2011-10-27
2010-12-31433.76M shares
derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-21
216.94M shares
derived: average of 2 quarters · filed 2013-02-21
108.52M shares
10-K · filed 2013-02-21
2010-09-30108.67K shares
10-Q · filed 2011-10-27
108.37K shares
10-Q · filed 2011-10-27
2009-12-31107.07M shares
10-K · filed 2012-02-22

Similar stocks

Stock NameCountryMarket CapPE Ratio
NEUROCRINE BIOSCIENCES INC (NBIX)United States$14.131B24.25
HALOZYME THERAPEUTICS, INC. (HALO)United States$13.083B21.59
Twist Bioscience Corp (TWST)United States$11.540B-47.21
BIO-TECHNE Corp (TECH)United States$11.379B74.68
REPLIGEN CORP (RGEN)United States$10.755B185.31
Krystal Biotech, Inc. (KRYS)United States$10.210B45.56
Kymera Therapeutics, Inc. (KYMR)United States$9.631B-31.69
ImmunityBio, Inc. (IBRX)United States$9.157B-9.29
Vaxcyte, Inc. (PCVX)United States$8.466B-7.91
Immunovant, Inc. (IMVT)United States$7.028B-14.78